Saccharic acid 1.4-lactone protects against CPT-11-induced mucosa damage in rats
- 25 May 2004
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 130 (7), 388-394
- https://doi.org/10.1007/s00432-004-0557-8
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Protective effect of oral phosphatidylcholine on radiation-induced release of intestinal peptidases in ratsZeitschrift für Krebsforschung und Klinische Onkologie, 2001
- Prevention of intestinal toxic effects and intensification of irinotecan's therapeutic efficacy against murine colon cancer liver metastases by oral administration of the lipopeptide JBT 3002.1998
- Gastrointestinal toxicity or irinotecan.1998
- Regulation and Significance of Apoptosis in the Stem Cells of the Gastrointestinal EpitheliumThe International Journal of Cell Cloning, 1997
- Characterisation and Clinical Management of CPT-11 (Irinotecan)-induced Adverse Events: The European PerspectiveEuropean Journal Of Cancer, 1996
- Protective Effects of Kampo Medicines and Baicalin against Intestinal Toxicity of a New Anticancer Camptothecin Derivative, Irinotecan Hydrochloride (CPT‐11), in RatsJapanese Journal of Cancer Research, 1995
- Phase I and pharmacokinetic trial of weekly CPT-11.Journal of Clinical Oncology, 1993
- CPT-11-induced cholinergic effects in cancer patients.Journal of Clinical Oncology, 1993
- METABOLISM AND PHARMACOKINETICS OF THE CAMPTOTHECIN ANALOG CPT-11 IN THE MOUSE1990
- Phosphorus Assay in Column ChromatographyJournal of Biological Chemistry, 1959